BridgeMD
New treatment option for Hypertension
Official title Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
ClinicalTrials.gov ID: NCT07461415
What this study is testing
- What it's testing
- The investigators propose an intervention that leverages the success of Community Healthcare Workers (CHWs) and telehealth to connect patients with severe hypertension from Emergency Department (ED) to primary care resources and to coach them to adopt evidence-based, practical lifestyle solutions relevant to urban living. The investigators have proposed this intervention as "Coaching and Navigation by Community Health Workers (CHWs) through Telehealth for High-risk Hypertension: CONNECT-HTN intervention.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Eligible patients
- Must be over the age of 18 years
- Have an ED triage SBP \> 180 and/or DBP \> 110, with a repeat similar reading ≥30 minutes after triage
- May have received treatment for elevated BP, but must have no evidence of end-organ damage (acute stroke, acute coronary syndrome, acute kidney...
- May be admitted for deranged BP only with no complications, or may be stable for discharge per treating emergency physician
You likely can't join if
- Given that hypertension is defined and treated differently, we will exclude
- pregnant patients
- terminally ill patients, as well as
- those requiring admission to the hospital due to severe complications (other than deranged BP).
See the full eligibility criteria
- Eligible patients
- Must be over the age of 18 years
- Have an ED triage SBP \> 180 and/or DBP \> 110, with a repeat similar reading ≥30 minutes after triage
- May have received treatment for elevated BP, but must have no evidence of end-organ damage (acute stroke, acute coronary syndrome, acute kidney injury, or papilledema)
- May be admitted for deranged BP only with no complications, or may be stable for discharge per treating emergency physician
- Include referrals from the clinic to the ED with SBP/DBP values in the inclusion range
- Can provide informed consent. Intervention is accessible to individuals of all literacy levels
- Can receive phone calls and in-person visits. Smartphone ownership not required (intervention compatible with analog phones)
- Given that hypertension is defined and treated differently, we will exclude
- pregnant patients
- terminally ill patients, as well as
- those requiring admission to the hospital due to severe complications (other than deranged BP).
The study team makes the final eligibility decision.
Where it's taking place
- Karachi, Sindh, Pakistan
- Karachi, Pakistan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Karachi, Sindh, Pakistan; Karachi, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.